LONG COVID19

Clinical trials for LONG COVID19 explained in plain language.

Never miss a new study

Get alerted when new LONG COVID19 trials appear

Sign up with your email to follow new studies for LONG COVID19, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Completed 2

Could a simple pill tame the immune chaos of long COVID POTS?

Disease control Recruiting now

This study tests whether a drug called 2-HOBA can reduce immune system overactivity in people with Long COVID-related POTS, a condition causing fatigue, dizziness, and rapid heartbeat. Researchers will give 50 participants either 2-HOBA or a placebo for 28 days and measure change…

Matched conditions: LONG COVID19

Phase: PHASE2 • Sponsor: Vanderbilt University Medical Center • Aim: Disease control

Last updated Apr 29, 2026 03:07 UTC

LONG COVID19

Get alerted when new LONG COVID19 trials appear

Could a simple pill tame the immune chaos of long COVID POTS?